PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 107 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $67,000 | +219.0% | 17,512 | +389.0% | 0.00% | – |
| Q4 2017 | $21,000 | -19.2% | 3,581 | 0.0% | 0.00% | – |
| Q3 2017 | $26,000 | +8.3% | 3,581 | 0.0% | 0.00% | – |
| Q2 2017 | $24,000 | -29.4% | 3,581 | 0.0% | 0.00% | – |
| Q1 2017 | $34,000 | +9.7% | 3,581 | 0.0% | 0.00% | – |
| Q4 2016 | $31,000 | -56.9% | 3,581 | -68.6% | 0.00% | – |
| Q3 2016 | $72,000 | -48.2% | 11,387 | -65.4% | 0.00% | -100.0% |
| Q2 2016 | $139,000 | -2.8% | 32,915 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $143,000 | -88.5% | 32,915 | -83.7% | 0.00% | -83.3% |
| Q4 2015 | $1,241,000 | +14.4% | 202,488 | +6.7% | 0.01% | 0.0% |
| Q3 2015 | $1,085,000 | -0.2% | 189,776 | +30.2% | 0.01% | +20.0% |
| Q2 2015 | $1,087,000 | +1475.4% | 145,727 | +1159.0% | 0.01% | – |
| Q1 2015 | $69,000 | -40.0% | 11,575 | -23.8% | 0.00% | -100.0% |
| Q4 2014 | $115,000 | +45.6% | 15,186 | 0.0% | 0.00% | – |
| Q3 2014 | $79,000 | -16.0% | 15,186 | -30.5% | 0.00% | – |
| Q2 2014 | $94,000 | +5.6% | 21,846 | 0.0% | 0.00% | – |
| Q1 2014 | $89,000 | -23.3% | 21,846 | 0.0% | 0.00% | -100.0% |
| Q4 2013 | $116,000 | +5.5% | 21,846 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $110,000 | – | 21,846 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |